jueves, 27 de octubre de 2011

ABBOTT la paga...por Depakote.

Abbott's Depakote: alleged to have been marketed outside of licence

Abbott could be liable to pay $1.3 billion to settle claims it illegally marketed the epilepsy drug Depakote.

Abbott is said to have reached an agreement that would see the firm pay around $800 million for civil claims and about $500 million in criminal penalties, according to sources speaking to Bloomberg. (Ver)


No hay comentarios: